Artner O, Bohm M, et al Cardiovascular illness and dyslipidemia: beyond LDL. Existing pharmaceutical design, 17: 861870. 11. Holzmann MJ, Jungner I, Walldius G, Ivert T, Nordqvist T, et al Dyslipidemia is a robust predictor of myocardial infarction in subjects with chronic kidney illness. Annals of medicine, 44: 262270. 12. Masson D, Jiang X-C, Lagrost L, Tall AR The role of plasma lipid transfer proteins in lipoDocosahexaenoyl ethanolamide web protein metabolism and atherogenesis. Journal of lipid analysis, 50: S201S206. 13. Rader DJ, Alexander ET, Weibel GL, Billheimer J, Rothblat GH The role of reverse cholesterol transport in animals and humans and connection to atherosclerosis. Journal of lipid investigation, 50: S189S194. 14. Tall AR Functions of cholesterol ester transfer protein and partnership to coronary artery illness danger. J Clin Lipidol, four: 389393. 15. Cooney M, Dudina A, De Bacquer D, Wilhelmsen L, Sans S, et al HDL cholesterol protects against cardiovascular illness in both genders, at all ages and at all levels of risk. Atherosclerosis, 206: 611616. 16. von Eckardstein A Implications of torcetrapib failure for the future of HDL therapy: is HDL-cholesterol the proper target Specialist Rev Cardiovasc Ther, 8: 345358. 17. Qian Y, Pu Y, Liu L, Wang DZ, Zhao X, et al Low HDL-C level is associated using the improvement of intracranial artery stenosis: evaluation from the Chinese IntraCranial AtheroSclerosis study. PLoS One particular, 8: e64395. 18. Boekholdt SM, Arsenault BJ, Hovingh GK, Mora S, Pedersen TR, et al Levels and changes of HDL cholesterol and apolipoprotein A-I in relation to threat of cardiovascular events among statin-treated individuals: a meta-analysis. Circulation, 128: 15041512. 19. Barn K, Laftavi M, Pierce D, Ying C, Boden WE, et al Low levels of highdensity lipoprotein cholesterol: an independent threat aspect for late adverse cardiovascular events in renal transplant recipients. Transpl Int, 23: 574579. 20. Wu JH, Lee YT, Hsu HC, Hsieh LL Influence of CETP gene variation on plasma lipid levels and coronary heart disease: a survey in Taiwan. Atherosclerosis, 159: 451458. 21. Ridker PM, Pare G, Parker AN, Zee RY, Miletich JP, et al Polymorphism inside the CETP Gene Area, HDL Cholesterol, and Danger of Future Myocardial Infarction Genomewide Evaluation Among 18 245 Initially Healthy Females From the Women’s Genome Health Study. Circ Cardiovasc Genet, two: 2633. 11 CETP Gene Polymorphisms and MI Risk 22. Thompson JF, 18325633 Durham LK, Lira ME, Shear C, Milos PM CETP polymorphisms connected with HDL cholesterol might differ from those linked with cardiovascular disease. Atherosclerosis, 181: 4553. 23. Drayna D, Jarnagin AS, McLean J, Henzel W, Kohr W, et al Cloning and sequencing of human cholesteryl ester transfer protein cDNA. Nature, 327: 632634. 24. Ordovas JM Genetic polymorphisms and activity of cholesterol ester transfer protein: need to we be measuring them Clin Chem Lab Med, 38: 945949. 25. van Venrooij FV, Stolk RP, Banga J-D, Sijmonsma TP, van Tol A, et al Frequent cholesteryl ester transfer protein gene polymorphisms plus the impact of atorvastatin therapy in type two diabetes. Diabetes Care, 26: 12161223. 26. Dullaart RP, Sluiter WJ Common variation inside the CETP gene plus the implications for cardiovascular Homotaurine site disease and its therapy: an updated evaluation. Pharmacogenomics 2008 Jun, 9:747763. 27. Mohrschladt MF, van der Sman-de Beer F, Hofman MK, van der Krabben M, Westendorp RG, et al TaqIB polymorphism in CETP gene: the influence on incidence of cardiovascular disease in statin.Artner O, Bohm M, et al Cardiovascular illness and dyslipidemia: beyond LDL. Existing pharmaceutical style, 17: 861870. 11. Holzmann MJ, Jungner I, Walldius G, Ivert T, Nordqvist T, et al Dyslipidemia is actually a sturdy predictor of myocardial infarction in subjects with chronic kidney disease. Annals of medicine, 44: 262270. 12. Masson D, Jiang X-C, Lagrost L, Tall AR The function of plasma lipid transfer proteins in lipoprotein metabolism and atherogenesis. Journal of lipid investigation, 50: S201S206. 13. Rader DJ, Alexander ET, Weibel GL, Billheimer J, Rothblat GH The role of reverse cholesterol transport in animals and humans and connection to atherosclerosis. Journal of lipid study, 50: S189S194. 14. Tall AR Functions of cholesterol ester transfer protein and partnership to coronary artery disease threat. J Clin Lipidol, four: 389393. 15. Cooney M, Dudina A, De Bacquer D, Wilhelmsen L, Sans S, et al HDL cholesterol protects against cardiovascular illness in both genders, at all ages and at all levels of threat. Atherosclerosis, 206: 611616. 16. von Eckardstein A Implications of torcetrapib failure for the future of HDL therapy: is HDL-cholesterol the proper target Specialist Rev Cardiovasc Ther, 8: 345358. 17. Qian Y, Pu Y, Liu L, Wang DZ, Zhao X, et al Low HDL-C level is associated with the development of intracranial artery stenosis: evaluation from the Chinese IntraCranial AtheroSclerosis study. PLoS One, 8: e64395. 18. Boekholdt SM, Arsenault BJ, Hovingh GK, Mora S, Pedersen TR, et al Levels and modifications of HDL cholesterol and apolipoprotein A-I in relation to threat of cardiovascular events amongst statin-treated patients: a meta-analysis. Circulation, 128: 15041512. 19. Barn K, Laftavi M, Pierce D, Ying C, Boden WE, et al Low levels of highdensity lipoprotein cholesterol: an independent risk issue for late adverse cardiovascular events in renal transplant recipients. Transpl Int, 23: 574579. 20. Wu JH, Lee YT, Hsu HC, Hsieh LL Influence of CETP gene variation on plasma lipid levels and coronary heart disease: a survey in Taiwan. Atherosclerosis, 159: 451458. 21. Ridker PM, Pare G, Parker AN, Zee RY, Miletich JP, et al Polymorphism within the CETP Gene Area, HDL Cholesterol, and Danger of Future Myocardial Infarction Genomewide Evaluation Amongst 18 245 Initially Healthier Girls In the Women’s Genome Wellness Study. Circ Cardiovasc Genet, two: 2633. 11 CETP Gene Polymorphisms and MI Threat 22. Thompson JF, 18325633 Durham LK, Lira ME, Shear C, Milos PM CETP polymorphisms related with HDL cholesterol may well differ from these associated with cardiovascular illness. Atherosclerosis, 181: 4553. 23. Drayna D, Jarnagin AS, McLean J, Henzel W, Kohr W, et al Cloning and sequencing of human cholesteryl ester transfer protein cDNA. Nature, 327: 632634. 24. Ordovas JM Genetic polymorphisms and activity of cholesterol ester transfer protein: should really we be measuring them Clin Chem Lab Med, 38: 945949. 25. van Venrooij FV, Stolk RP, Banga J-D, Sijmonsma TP, van Tol A, et al Prevalent cholesteryl ester transfer protein gene polymorphisms and also the impact of atorvastatin therapy in sort 2 diabetes. Diabetes Care, 26: 12161223. 26. Dullaart RP, Sluiter WJ Common variation inside the CETP gene and also the implications for cardiovascular disease and its remedy: an updated analysis. Pharmacogenomics 2008 Jun, 9:747763. 27. Mohrschladt MF, van der Sman-de Beer F, Hofman MK, van der Krabben M, Westendorp RG, et al TaqIB polymorphism in CETP gene: the influence on incidence of cardiovascular disease in statin.
